Daniel Stelzl

Universität Hamburg, Brigham and Women's Hospital

Papers

Total Citations

H-Index

About

Daniel Stelzl is a pioneering urologic surgeon and researcher whose work is reshaping the surgical management of genitourinary cancers, with a particular focus on testicular and prostate malignancies. His major contributions center on advancing minimally invasive robotic techniques to improve patient outcomes and reduce morbidity. Stelzl’s landmark 2025 study on robotic retroperitoneal lymph node dissection (R-RPLND) for testicular cancer, with 7 citations, demonstrated the feasibility and oncological safety of this approach, challenging the traditional open surgery gold standard and offering patients a less invasive option with potentially fewer complications. In parallel, his 2024 analysis of same-day discharge trends for robot-assisted laparoscopic prostatectomy, drawing on the National Cancer Database and garnering 4 citations, provided critical insights into the safety and evolving practice patterns during the pandemic era. This work has informed perioperative protocols and enhanced patient recovery pathways. Stelzl’s research is notable for its direct clinical impact, bridging surgical innovation with real-world data to optimize cancer care. His contributions are particularly valuable for trainees and researchers interested in the intersection of robotic surgery, oncological safety, and health system efficiency.